LONDON--(BUSINESS WIRE)--Technavio analysts forecast the global bipolar disorder therapeutics market to grow at a CAGR of over 2% during the forecast period, according to their latest market research report.
The increasing strategic alliances are one of the major trends being witnessed in the global bipolar disorder therapeutics market 2019-2023. Vendors are focusing on strategic alliances to enter the market. As a result of the entry of several new vendors, the competition in the market is intensifying, and the profit margins of vendors are decreasing. To maintain their market position, the key vendors are entering strategic alliances to strengthen their product portfolio in new regions.
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
According to Technavio analysts, one of the key factors contributing to the growth of the global bipolar disorder therapeutics market is the increasing R&D funding:
Global bipolar disorder therapeutics market: Increasing R&D funding
The rise in the incidence of chronic diseases has encouraged public and private sectors to work on improving the healthcare infrastructure and increasing the healthcare expenditure to provide advanced solutions.
According to a senior analyst at Technavio, “The growth of the healthcare industry is supported by the increase in R&D, which leads to improved diagnosis and treatment of CNS ailments. For instance, the NIH’s R&D funding for bipolar disorder increased from USD 80 million in 2015 to USD 88 million in 2017. Such significant investments in R&D will encourage vendors to introduce novel therapeutics for bipolar disorder, thus supporting the growth of the market.”
Global bipolar disorder therapeutics market: Segmentation analysis
The global bipolar disorder therapeutics market research report provides market segmentation by product (antipsychotics, anticonvulsants, traditional mood stabilizers, and others) and by region (the Americas, EMEA, and APAC). It provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.
The antipsychotics segment held the largest market share in 2018, contributing to over 45% of the market. This product segment will continue to dominate the global market throughout the forecast period.
The Americas held the largest share of the market in 2018, accounting for more than 52% share, followed by EMEA and APAC respectively. The region is expected to continue to dominate the market during the forecast period.
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Market definition
- Market size and forecast
Five Forces Analysis
- Regional comparison
- Key leading countries
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at email@example.com.